Closing the diagnostic gap: Liquid biopsy potential to transform ovarian cancer outcomes in sub-Saharan Africa

Emmanuel Kokori,Gbolahan Olatunji,Ikponmwosa Jude Ogieuhi,Ifeanyichukwu Muogbo,David Isarinade,Bonaventure Ukoaka,Irene Ajayi,Chidiogo Ezenwoba,Owolabi Samuel,Habeebat Nurudeen-Busari,David B. Olawade,Nicholas Aderinto
DOI: https://doi.org/10.1097/md.0000000000037154
IF: 1.6
2024-02-03
Medicine
Abstract:Ovarian cancer is a significant global health concern, and its impact is particularly pronounced in sub-Saharan Africa (SSA). In 2020, SSA witnessed almost 18,000 cases of ovarian cancer, resulting in 13,000 deaths. [ 1 ] This accounted for 2.2% of all cancer cases in the region, with ovarian cancer ranking as the fourth most common neoplasm among women. [ 1 ] The region faces unique challenges in the diagnosis and management of ovarian cancer, leading to a considerable diagnostic gap.
medicine, general & internal
What problem does this paper attempt to address?